Safety and effects of UBT38006 injection in healthy men
Treatments studied
Part of Hormones & metabolism clinical trials.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18–45 years old
- You weigh at least 50 kg (110 lbs) and have a healthy BMI between 19–24
- Your blood sugar levels are normal based on fasting and glucose-tolerance tests
- You are willing to use reliable birth control and avoid donating sperm for 3 months after the injection
- You have no serious allergies, chronic diseases, or recent major surgery
- You are not taking insulin, most other medications, or have used drugs in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
This is an early-stage safety study of a new drug called IBI3035 in healthy adult volunteers. Researchers want to understand how the drug is absorbed and processed by the body, and whether it causes any side effects.
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
This study tests a new medication (UI087) in healthy volunteers to see how safe it is and how the body processes it, compared to taking three separate medicines together. It's an early-phase trial that may help future patients with a similar treatment option.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.